Literature DB >> 21279865

Prevalence of illicit drug use among the Italian athlete population with special attention on drugs of abuse: a 10-year review.

Sabina Strano Rossi1, Francesco Botrè.   

Abstract

The objective of this study was to assess the prevalence of illicit drugs use among young adults, in particular elite athletes. This study considers the data obtained from anti-doping analyses performed on nearly 100,000 urine samples from 2000 to 2009 by the World Anti-Doping Agency accredited Italian Anti-Doping Laboratory. The percentage of adverse analytical findings varies on a yearly basis, but it is in the range 1.0-1.8% (not considering atypical findings, such as an altered endogenous steroid profile). Among positive results, there is a high prevalence of stimulants and drugs of abuse. The drug of abuse found most frequently is the tetrahydrocannabinol (cannabis) metabolite, accounting for 0.2-0.4% of the total samples analysed (18% of the positive results). The second most frequently encountered drug is cocaine, as detected from cocaine metabolites, accounting for 0.1% of the total samples analysed (7% of positive results). Other stimulants found included amphetamines, ephedrines, carphedon, modafinil, and anorexic compounds. No amphetamine-like designer drugs were detected. These data are indicative of the widespread prevalence of cocaine and cannabis use among the young adult population. However, due to the particular population studied, it must be considered an underestimation of the phenomenon among elite athletes with respect to the general population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21279865     DOI: 10.1080/02640414.2010.543915

Source DB:  PubMed          Journal:  J Sports Sci        ISSN: 0264-0414            Impact factor:   3.337


  9 in total

Review 1.  Prevalence of doping use in elite sports: a review of numbers and methods.

Authors:  Olivier de Hon; Harm Kuipers; Maarten van Bottenburg
Journal:  Sports Med       Date:  2015-01       Impact factor: 11.136

Review 2.  Current knowledge on cannabinoids in oral fluid.

Authors:  Dayong Lee; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2013-08-25       Impact factor: 3.345

3.  Cannabis Use and Sport: A Systematic Review.

Authors:  Shgufta Docter; Moin Khan; Chetan Gohal; Bheeshma Ravi; Mohit Bhandari; Rajiv Gandhi; Timothy Leroux
Journal:  Sports Health       Date:  2020-02-05       Impact factor: 3.843

4.  A strategy to reduce illicit drug use is effective in elite Australian football.

Authors:  Peter R Harcourt; Harry Unglik; Jill L Cook
Journal:  Br J Sports Med       Date:  2012-08-14       Impact factor: 13.800

5.  Prevalence, knowledge and attitude of prohibited substances use (doping) among Saudi sport players.

Authors:  M Al Ghobain; M S Konbaz; A Almassad; A Alsultan; M Al Shubaili; O AlShabanh
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-04-16

6.  Modafinil Induces Rapid-Onset Behavioral Sensitization and Cross-Sensitization with Cocaine in Mice: Implications for the Addictive Potential of Modafinil.

Authors:  Raphael Wuo-Silva; Daniela F Fukushiro; André W Hollais; Renan Santos-Baldaia; Elisa Mári-Kawamoto; Laís F Berro; Thaís S Yokoyama; Leonardo B Lopes-Silva; Carolina S Bizerra; Roberta Procópio-Souza; Debora Hashiguchi; Lilian A Figueiredo; Jose L Costa; Roberto Frussa-Filho; Beatriz M Longo
Journal:  Front Pharmacol       Date:  2016-11-07       Impact factor: 5.810

7.  The use of performance-enhancing substances (doping) by athletes in Saudi Arabia.

Authors:  Mohammed Al Ghobain
Journal:  J Family Community Med       Date:  2017 Sep-Dec

8.  Illicit Drug Use Among Gym-Goers: a Cross-sectional Study of Gym-Goers in Sweden.

Authors:  Yasmina Molero; Ann-Sofie Bakshi; Johanna Gripenberg
Journal:  Sports Med Open       Date:  2017-08-29

9.  The prevalence of doping among Saudi athletes: Results from the National Anti-Doping Program.

Authors:  Sulaiman O Aljaloud; Khalid I Khoshhal; Abdullatif A Al-Ghaiheb; Mohammed S Konbaz; Abdulaziz A Almasaed
Journal:  J Taibah Univ Med Sci       Date:  2020-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.